trial · primary record
18F-DCFPyL
Prostate Neoplasms
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 385 |
| Primary completion | 2031-02-01 |
| Primary endpoint | To assess the ability of 18F-DCFPyL to accurately stage high-risk primary prostate cancer and detect sites of recurrent prostate cancer |
| Registry ID | NCT03181867 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:31.538Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03181867
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.